FDA Drug Application (202343) for JUVISYNC by MERCK SHARP DOHME

Back to FDA Applications sponsored by MERCK SHARP DOHME

Application Number202343
Product Number001
FormTABLET;ORAL
Dosage10MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameJUVISYNC
Active IngredientSIMVASTATIN; SITAGLIPTIN PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient SIMVASTATIN6
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by MERCK SHARP DOHME